Guselkumab as a Possible New Treatment for Psoriasis

Abstract

Introduction: In Mexico it affects approximately 2 million people, with a significant impact on quality of life and difficult to manage. Theoretical framework:The lesion it causes is round, salmon-pink papules and plaques, located on knees, elbows and scalp. The diagnosis is mainly clinical and the treatment will depend on the affected body surface and the location. The drugs considered first line are topical and second line drugs are used systemically, which in many occasions have adverse effects that make attachment difficult. Guselkumab, a drug approved in 2017, is an IgG1 that blocks the p19 subunit of IL-23.Discussion: Guselkumab, which is a monoclonal antibody, provides better patient outcomes compared to the drugs used in current therapeutics. There is little information currently available on Guselkumab since it has only recently been approved, butin all studies it has shown to be superior to other monoclonal antibodies, the main disadvantage being that it is not currently available in Mexico and the long administration time.Conclusion: Researching new drugs helps us to provide the patient with atreatment with the least amount of adverse effects, achieving greater adherence and better control of the disease.

Authors and Affiliations

Ingrid Pamela Rodríguez Minguela ,María Fernanda Gámez Acosta ,Zuleyka Roxana Martínez Martínez , Edit Cano Muñoz , Alfredo López Gómez ,Nallely Olivera Ruiz , Monserrat Espinosa Ramos

Keywords

Related Articles

How to Avoid Pseudoptosis after Lifting and Breast Reduction Mammaplasties

Pseudoptosisor “bottoming-out” is a common complication following breast reduction. It is secondary to five causal phenomena: improper determination of nipple placement, dissociation of the nipple from the gland, dissoci...

Development of a Bioresorbable Implant for Nasal Valve Collapse

The aim of the present study is to report outcomes after treatment of nasal valve collapse with a bioabsorbable nasal implant. Nasal obstruction is a main occurrence of breathing difficulties, with lateral wall insuffi...

Identifying Risk Factors for Complicated Duodenal Ulcer in Children

In recent years, there has been an increase in the incidence of duodenal ulcer and an increase in the number of complicated forms. Bleeding from duodenal ulcers is the most formidable complication and occupies one of the...

Buschke-Lowenstein Tumor and its Medical-Surgical Approach

Buschke-Lowenstein tumor is a benign lesion of the skin and mucosa that occurs most commonly in the genital and perianal region of sexually active men and women. It is associated with human papillomavirus...

Evaluation of Reducing the Excess Abdominal Skin, Subcutaneous Tissue and Anterior Abdominal Wall Laxity: A Prospective Observational Study at Dhaka Medical College Hospital

Background:Lax abdominal muscles cause laxity or bulging. This is generally a consequence of age or post-pregnancy, causing the abdominal rectus muscles and fascia that overlies and divides them to weaken. Abdominoplasty...

Download PDF file
  • EP ID EP740091
  • DOI 10.47191/ijmscrs/v3-i5-04
  • Views 38
  • Downloads 0

How To Cite

Ingrid Pamela Rodríguez Minguela, María Fernanda Gámez Acosta, Zuleyka Roxana Martínez Martínez, Edit Cano Muñoz, Alfredo López Gómez, Nallely Olivera Ruiz, Monserrat Espinosa Ramos (2023). Guselkumab as a Possible New Treatment for Psoriasis. International Journal Of Medical Science And Clinical Research Studies, 3(5), -. https://europub.co.uk./articles/-A-740091